Literature DB >> 15579028

The Eker rat: establishing a genetic paradigm linking renal cell carcinoma and uterine leiomyoma.

J D Cook1, C L Walker.   

Abstract

Renal Cell Carcinoma (RCC) and uterine leiomyoma (often referred to as fibroids) are tumors arising from tubular epithelium and myometrial compartments of the kidney and uterus, respectively. These tumors have a very different clinical presentation, with RCC being one of the less common cancers, having a very poor prognosis, and occurring predominantly in men, whereas uterine leiomyoma are the most common tumor of women and are benign. Although they are distinct histologically, with RCC arising from epithelial cells and leiomyoma arising from smooth muscle cells, they share a common embryological origin. Renal tubular epithelial cells arise during nephrogenesis as a result of the mesenchymal-epithelial transition of condensed mesenchyme induced by the developing ureteric bud, and have a shared mesenchymal lineage with smooth muscle cells of the uterus. In addition to a common embryological origin, RCC and leiomyoma have been demonstrated to share a common genetic etiology. The Eker rat model was the first demonstration of a specific genetic linkage between RCC and uterine leiomyoma. Eker rats carry a germline defect in the rat homologue of the tuberous sclerosis complex 2 (TSC-2) tumor suppressor gene and develop spontaneous RCC and uterine leiomyoma with a high frequency. TSC patients are also at risk for RCC, and sporadic human uterine leiomyomas exhibit loss of function of the TSC-2 gene product, tuberin. Individuals with the inherited cancer syndrome hereditary leiomyomatosis and renal cell cancer (HLRCC) that have germline defects in the fumarate hydratase (FH) gene develop papillary RCC and uterine and skin leiomyomas. Benign cutaneous lesions and uterine leiomyoma also arise in German Shepherd dogs with germline mutations in the Birt-Hogg-Dube (BHD) gene, and these animals develop RCC and uterine leiomyoma with a high frequency. Identification of the tumor suppressor genes involved in these diseases, TSC, FH and BHD, and the elucidation of the function of their protein products, tuberin, fumarate hydratase and folliculin, respectively, opens new avenues for understanding the pathogenesis of both RCC and uterine leiomyoma.

Entities:  

Mesh:

Year:  2004        PMID: 15579028     DOI: 10.2174/1566524043359656

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  18 in total

1.  Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.

Authors:  Sergio A Machado; Janice M Bahr; D Buck Hales; Andrea G Braundmeier; Bradley J Quade; Romana A Nowak
Journal:  Biol Reprod       Date:  2012-10-11       Impact factor: 4.285

Review 2.  Recent Advances in Uterine Fibroid Etiology.

Authors:  Michelle M McWilliams; Vargheese M Chennathukuzhi
Journal:  Semin Reprod Med       Date:  2017-03-09       Impact factor: 1.303

3.  Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.

Authors:  Masaya Baba; Seung-Beom Hong; Nirmala Sharma; Michelle B Warren; Michael L Nickerson; Akihiro Iwamatsu; Dominic Esposito; William K Gillette; Ralph F Hopkins; James L Hartley; Mutsuo Furihata; Shinya Oishi; Wei Zhen; Terrence R Burke; W Marston Linehan; Laura S Schmidt; Berton Zbar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-06       Impact factor: 11.205

Review 4.  The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.

Authors:  Qiwei Yang; Aymara Mas; Michael P Diamond; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2015-04-28       Impact factor: 3.060

5.  Endocrine disruptor exposure during development increases incidence of uterine fibroids by altering DNA repair in myometrial stem cells.

Authors:  Lauren E Prusinski Fernung; Qiwei Yang; Daitoku Sakamuro; Alpana Kumari; Aymara Mas; Ayman Al-Hendy
Journal:  Biol Reprod       Date:  2018-10-01       Impact factor: 4.285

6.  Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.

Authors:  Memy H Hassan; Salama A Salama; Dong Zhang; Hossam M M Arafa; Farid M A Hamada; Hala Fouad; Cheryl C Walker; Ayman Al-Hendy
Journal:  Fertil Steril       Date:  2009-01-14       Impact factor: 7.329

7.  Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway.

Authors:  Binny V Varghese; Faezeh Koohestani; Michelle McWilliams; Arlene Colvin; Sumedha Gunewardena; William H Kinsey; Romana A Nowak; Warren B Nothnick; Vargheese M Chennathukuzhi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-02       Impact factor: 11.205

8.  Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model.

Authors:  Memy Hassan; Dong Zhang; Salama Salama; Farid Hamada; Hossam Arafa; Hala Fouad; Cheryl Walker; Ayman Al-Hendy
Journal:  Gynecol Obstet Invest       Date:  2009-03-27       Impact factor: 2.031

Review 9.  The role of HIF1α in renal cell carcinoma tumorigenesis.

Authors:  Lorraine J Gudas; Leiping Fu; Denise R Minton; Nigel P Mongan; David M Nanus
Journal:  J Mol Med (Berl)       Date:  2014-06-12       Impact factor: 4.599

10.  Vitamin D3 Inhibits Wnt/β-Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells.

Authors:  Ayman Al-Hendy; Michael P Diamond; Thomas G Boyer; Sunil K Halder
Journal:  J Clin Endocrinol Metab       Date:  2016-01-28       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.